Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Alzheimer Disorders

Volume 1

eBook: US $129 Special Offer (PDF + Printed Copy): US $219
Printed Copy: US $155
Library License: US $516
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-1-60805-723-8 (Print)
ISBN: 978-1-60805-722-1 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080572211130101


Frontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimers Disease research.


- Pp. i-ii (2)
Download Free

List of Contributors

- Pp. iii-vi (4)
Download Free

Immunotherapy with Anti-Aβ Monoclonal Antibodies in Alzheimer’s Disease: A Critical Review on the Molecules in the Pipelines with Regulatory Considerations

- Pp. 3-85 (83)
Chrystelle Mavoungou, Katharina Schindowski Zimmerman
View Abstract

The Development of Multi-Target-Directed Ligands (MTDL) to Treat Alzheimer’s Disease

- Pp. 86-108 (23)
John W. Wright, Joseph W. Harding
View Abstract

Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside

- Pp. 109-146 (38)
Rosaria A. Cavallaro, Andrea Fuso
View Abstract

Tau-Directed Therapies for Alzheimer’s Disease and Other Tauopathies

- Pp. 147-182 (36)
Yasumasa Yoshiyama
View Abstract

Different Approaches in the Treatment of Alzheimer's Disease: Comprehensive Insight

- Pp. 183-216 (34)
Zaciragic Asija
View Abstract

Alzheimer’s Disease and Dementia: A Midlife Approach to Treatment is Needed

- Pp. 217-242 (26)
Angela Clifford, Jennifer Stock, Stephan Bandelow, Tri Budi Rahardjo, Eef Hogervorst
View Abstract

Neurogenic Molecules Modulating Cell Survival Pathways, Amyloid Beta, Tau Proteins, and Metal Dyshomeostasis: An Alternative Hope for Alzheimer’s Therapy

- Pp. 243-264 (22)
Hailin Zheng, Mati Fridkin, Moussa B.H. Youdim
View Abstract

Cognitive Decline and Alzheimer's Disease: A Central Role for Hypoxia-Obstructive Sleep Apnea and Related Stigmata in Elderly

- Pp. 265-314 (50)
Mak Adam Daulatzai
View Abstract

Pharmacotherapies for Alzheimer’s Disease: From Natural Compounds to Target Synthetic Drugs

- Pp. 315-366 (52)
Chuang Wang, Rui Wang, James M. O’Donnell, Ying Xu
View Abstract

Challenges in the Morphological Diagnosis of Dementias

- Pp. 367-410 (44)
Kurt A. Jellinger
View Abstract

Metal Ions in the Pathogenesis of Alzheimer’s Disease: An Open Field

- Pp. 411-431 (21)
Guido Crisponi, Valeria M. Nurchi, Daniela Fanni, Clara Gerosa, Sonia Nemolato, Miriam Crespo-Alonso, Leonardo Toso, Joanna I. Lachowicz, Gavino Faa
View Abstract


- Pp. 432-456 (25)
Download Free


.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Advances in Alzheimer Research.